Patent details

88856 Product Name: Doxorubicine liposomale pegylatée ou un sel pharmaceutiquement acceptable de celle-ci.

Basic Information

Publication number:
88856
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP893098368
Legal Status:
Expired
Application number:
88856
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/96/011/001+ 002
Marketing Authorization Type:
Marketing Authorization Date:
21/06/1996
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
18/12/1996
First Marketing Authorization date:
21/06/1996
Grant date:
31/01/1997
Activation date:
27/09/2009
Publication date:
31/01/1997
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
21/06/2011
SPC Extension Expiration:
21/06/2011
Rejection date:
Withdrawal date:

Owner

From:
18/12/1996
 
 

Name:
YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
Address:
JABOTINSKY STREET 46, 91042, JERUSALEM, Israel (IL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/12/1996
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:
Filing date Document type Number of pages